Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

Pertussis is still observed in many countries despite of high vaccine coverage. Acellular pertussis (aP) vaccination is widely implemented in many countries as primary series in infants and as boosters in school-entry/adolescents/adults (including pregnant women in some). One novel strategy to impro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Immunol
Prif Awduron: Auderset, Floriane, Ballester, Marie, Mastelic-Gavillet, Beatris, Fontannaz, Paola, Chabaud-Riou, Martine, Reveneau, Nathalie, Garinot, Marie, Mistretta, Noëlle, Liu, Yuanqing, Lambert, Paul-Henri, Ochs, Martina, Siegrist, Claire-Anne
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2019
Pynciau:
Immunology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6618515/
https://ncbi.nlm.nih.gov/pubmed/31333656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01520
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg